Amps Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -32.12%
- Profit Growth 19.52%
- Ebitda 33.40%
- Net Worth -34.10%
- Total Assets 37.32%
About Amps Biotech
Amps Biotech Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 September 2020 (Four years and four months 13 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Abhishek Agarwal and Piyush Agarwal serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299MH2020PTC346683
-
Company No.
346683
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Sep 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Amps Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Agarwal
|
Director | 25-Sep-2020 | Current |
|
Piyush Agarwal
|
Director | 25-Sep-2020 | Current |
Financial Performance of Amps Biotech.
Amps Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.12% decrease. The company also saw a substantial improvement in profitability, with a 19.52% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amps Biotech?
Unlock access to Amps Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Srm Motors Private LimitedPiyush Agarwal is a mutual person
-
Mg Autosales Private LimitedAbhishek Agarwal is a mutual person
-
Pralaksh Automobiles Private Limited
Piyush Agarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amps Biotech?
Amps Biotech has a workforce of 7 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amps Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amps Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.